Showing results (281-290 of 1,019) with videos related to

Sort By:
Pageof 102
Clinicoeconomics and Outcomes Research : CEOR|January 10, 2022
Direct and Indirect Costs of Asthma Burden in Abu Dhabi: A Retrospective Analysis of Insurance Claims Data from 2015 to 2018Khulood Al Mazrouei, Asma Ibrahim Almannaei, Faiza Medeni Nur, et al.
Clinicoeconomics and Outcomes Research : CEOR|January 8, 2015
Cost-consequence analysis of long-term prophylaxis in the treatment of von Willebrand disease in the Italian contextPiercarla Schinco, Dorina Cultrera, Federica Valeri, et al.
Clinicoeconomics and Outcomes Research : CEOR|December 16, 2014
Seriousness, preventability, and burden impact of reported adverse drug reactions in Lombardy emergency departments: a retrospective 2-year characterizationValentina Perrone, Valentino Conti, Mauro Venegoni, et al.
Clinicoeconomics and Outcomes Research : CEOR|January 1, 2016
Adjustment of foreign EQ-5D-3L utilities can increase their transferabilityLars Oddershede, Karin Dam Petersen
Clinicoeconomics and Outcomes Research : CEOR|August 9, 2018
Impact of comorbidity on the risk and cost of hospitalization in HIV-infected patients: real-world data from Abruzzo RegionSimona Cammarota, Anna Citarella, Lamberto Manzoli, et al.
Clinicoeconomics and Outcomes Research : CEOR|August 9, 2018
Procedure costs associated with the use of Harmonic devices compared to conventional techniques in various surgeries: a systematic review and meta-analysisHang Cheng, Jeffrey W Clymer, Rana A Qadeer, et al.
Clinicoeconomics and Outcomes Research : CEOR|April 20, 2018
The economic and clinical burden of early versus late initiation of celecoxib among patients with osteoarthritisAhmed Shelbaya, Caitlyn T Solem, Chris Walker, et al.
Clinicoeconomics and Outcomes Research : CEOR|May 5, 2022
Retrospective Database Analysis to Explore Patterns and Economic Burden of Switchback to Brand After Generic or Authorized Generic UtilizationJustine Alderfer, Jyoti Aggarwal, Kim Gilchrist, et al.
Clinicoeconomics and Outcomes Research : CEOR|May 5, 2022
Economic Burden of COVID-19: A Systematic ReviewFayolah Richards, Petya Kodjamanova, Xue Chen, et al.
Clinicoeconomics and Outcomes Research : CEOR|April 21, 2022
Clinical and Economic Benefits of Lenzilumab Plus Standard of Care Compared with Standard of Care Alone for the Treatment of Hospitalized Patients with Coronavirus Disease 19 (COVID-19) from the Perspective of National Health Service EnglandAdrian Kilcoyne, Edward Jordan, Kimberly Thomas, et al.
Pageof 102